Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model

利用新型类器官模型解决罕见神经内分泌癌的生物学和治疗差距

基本信息

项目摘要

This proposal responds to the provocative question PQ9: What methods can be developed to effectively study small or rare populations relevant to cancer research? We will address this question by generating organoid models of pheochromocytomas and paragangliomas (PPGL) to fill gaps in the mechanisms underlying tumor behavior and in therapeutic opportunities. PPGLs are rare catecholamine-secreting, neural crest-derived tumors originating from adrenal or extra adrenal paraganglia, respectively. Malignant PPGLs can only be recognized after detection of metastases, implying a late diagnosis. Approximately 30-40% of paragangliomas, and 10-15% of pheochromocytomas can develop metastases. In addition, PPGLs are clinically heterogeneous, can be recurrent and invasive, even without metastasis, but predictors of clinical behavior are lacking. Treatment options are currently limited, with modest effects on survival, and advances in this area are dampened by a scarcity of research models. Therefore, there is a critical need for developing models to uncover biological mechanisms that facilitate clinical outcome prediction and reveal molecular vulnerabilities which can be explored for therapeutic purposes. Our preliminary data indicate that we can successfully generate PPGL organoids that are amenable for drug screen. Our aims are: 1) to determine if PPGL organoids recapitulate features of the parental tumor; 2) to leverage PPGL organoids to investigate outstanding biological questions, including the existence of cell subtypes that may be related to tumor outcome, and 3) to utilize PPGL organoids for high- throughput drug screening that uncover vulnerabilities for future therapeutic testing, including novel leads suggested in our preliminary data. The proposed project will serve as a useful resource for designing future studies to decode the cellular and molecular mechanisms underlying PPGL development and clinical heterogeneity. Results from these studies may provide the groundwork for future testing of candidate drugs that might have immediate clinical application.
这一建议回应了PQ9这个挑衅性的问题:可以开发什么方法来有效地 研究与癌症研究相关的小群体或稀有群体?我们将通过生成 嗜铬细胞瘤和副神经节瘤(PPGL)的器官模型以填补潜在机制的空白 肿瘤的行为和治疗机会。PPGL是一种罕见的儿茶酚胺分泌物,由神经峰派生 肿瘤分别起源于肾上腺或肾上腺外副神经节。恶性PPGL只能是 在检测到转移后被识别的,意味着诊断较晚。大约30%-40%的副神经节瘤, 10-15%的嗜铬细胞瘤可发生转移。此外,PPGL在临床上是异质性的, 可能是复发和侵袭性的,即使没有转移,但缺乏临床行为的预测指标。治疗 目前选择有限,对生存的影响不大,这一领域的进展受到 研究模型的匮乏。因此,迫切需要开发模型来揭示生物学 促进临床结果预测和揭示可探索的分子脆弱性的机制 用于治疗目的。我们的初步数据表明,我们可以成功地产生PPGL有机化合物, 是要接受药物筛查的。我们的目标是:1)确定PPGL类有机物是否概括了 亲代肿瘤;2)利用PPGL有机类化合物调查悬而未决的生物学问题,包括 是否存在可能与肿瘤预后有关的细胞亚型,以及3)利用PPGL类有机化合物进行高转移。 吞吐量药物筛选,为未来的治疗测试发现漏洞,包括新的线索 在我们的初步数据中建议。拟议的项目将成为设计未来的有用资源。 破译PPGL发生和临床的细胞和分子机制的研究 异质性。这些研究的结果可能为未来对候选药物的测试提供基础 可能会立即在临床上应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICIA Leal DAHIA其他文献

PATRICIA Leal DAHIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICIA Leal DAHIA', 18)}}的其他基金

Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model
利用新型类器官模型解决罕见神经内分泌癌的生物学和治疗差距
  • 批准号:
    10818715
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model
利用新型类器官模型解决罕见神经内分泌癌的生物学和治疗差距
  • 批准号:
    10693929
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Interaction of the TMEM127 tumor suppressor with the mTORC1 lysosomal activating complex
TMEM127 肿瘤抑制因子与 mTORC1 溶酶体激活复合物的相互作用
  • 批准号:
    9311059
  • 财政年份:
    2017
  • 资助金额:
    $ 52.54万
  • 项目类别:

相似海外基金

Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10454300
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10666539
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10296199
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10854123
  • 财政年份:
    2021
  • 资助金额:
    $ 52.54万
  • 项目类别:
Interaction of adrenal glands and liver in canine hepatocellular carcinoma
犬肝细胞癌中肾上腺和肝脏的相互作用
  • 批准号:
    20H03139
  • 财政年份:
    2020
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of dendritic cells in adrenal glands of healthy and arthritic rats
树突状细胞在健康和关节炎大鼠肾上腺中的作用
  • 批准号:
    235438724
  • 财政年份:
    2013
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Research Grants
Role of neural cell adhesion molecules in structural and functional remodeling of fetal adrenal glands
神经细胞粘附分子在胎儿肾上腺结构和功能重塑中的作用
  • 批准号:
    20591305
  • 财政年份:
    2008
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search for the novel etiology in disorders of sex development (DSD) caused by abnormalities of adrenal glands and gonads.
寻找由肾上腺和性腺异常引起的性发育障碍 (DSD) 的新病因。
  • 批准号:
    16086202
  • 财政年份:
    2004
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Effects of endocrine disrupters on function of thyroid gland, adrenal glands and gonads
内分泌干​​扰物对甲状腺、肾上腺和性腺功能的影响
  • 批准号:
    11839003
  • 财政年份:
    1999
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles of Thyroid and Adrenal glands in the regulation of hypothalamo-hypophysial-ovarian axis in the rat.
甲状腺和肾上腺在大鼠下丘脑-垂体-卵巢轴调节中的作用。
  • 批准号:
    06660375
  • 财政年份:
    1994
  • 资助金额:
    $ 52.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了